Skip to main content
800.787.9659 | [email protected]
MultiMedRx home
  • Policies

    • Privacy Policy
    • Notice of Privacy Practices
    • Terms & Conditions
    • Legal Compliance
    • Return & Refund Policy

    Text Messages

    • SMS Terms
    • SMS Opt-in
  • Privacy Policy
  • Terms & Conditions
  • SMS Terms
Contact Us

Policies

  • Privacy Policy
  • Notice of Privacy Practices
  • Terms & Conditions
  • Legal Compliance
  • Return & Refund Policy

Text Messages

  • SMS Terms
  • SMS Opt-in
Contact Us →
800.787.9659 [email protected]

Legal Compliance

On this page

  1. 1. Licensing Compliance
  2. 2. Controlled Substances Practices
  3. 3. Provider Quality & Disciplinary Actions
  4. 4. Telemedicine & Establishing a Provider-Patient Relationship
  5. 5. Legal Compliance

1. Licensing Compliance

All providers, doctors, nurses, and other such practitioners affiliated with MultiMedRx™ (MMRx) are licensed and/or registered in good standing to engage in the practice of medicine and/or nursing in all jurisdictions in which they reside, and in jurisdictions in which they practice or render services to (such as the patient’s jurisdiction), except in circumstances allowed by law.

2. Controlled Substances Practices

All providers, doctors, nurses, and other such practitioners affiliated with MultiMedRx™ (MMRx) are licensed maintain an up to date and valid US Drug Enforcement Administration (DEA) license and any requisite state licenses as per state or local law. Controlled substances are only prescribed when a clear medical need exists that cannot be adequately met by the use of a non-controlled substance in the provider’s professional opinion.

Due to the complex nature of pain and the necessity for extremely thorough monitoring greater than telehealth can provide, no providers, doctors, nurses, and other such practitioners affiliated with MultiMedRx™ (MMRx). MultiMedRx™ (MMRx) prescribe or dispense prescription pain medication (opiates and/other narcotics) through telemedicine.

U.S. Department of Health and Human Services: If you suffer from pain, please see a local specialist and verify their licensing with the board of health via the following link: www.hhs.gov

3. Provider Quality & Disciplinary Actions

All providers, doctors, nurses, and other such practitioners affiliated with MultiMedRx™ (MMRx). MultiMedRx™ (MMRx) or to which patients are referred to are free from any significant recent and/or repeated disciplinary actions, sanctions, or similar. MultiMedRx™ (MMRx). MultiMedRx™ (MMRx) requires all affiliated providers to immediately notify our team in the event an affiliated provider is subject to any of the above actions.

4. Telemedicine & Establishing a Provider-Patient Relationship

All providers, doctors, nurses, and other such practitioners affiliated with MultiMedRx™ (MMRx). MultiMedRx™ (MMRx) conduct a full telehealth review before establishing a diagnosis, or the writing and/or dispensing of any medication. A prescription will only be provided when a:

  • a) The patient has a legitimate medical complaint;
  • b) A face-to-face physical examination adequate to establish the legitimacy of the medical complaint has been performed by the prescribing practitioner, or through a telemedicine practice approved by the appropriate practitioner board; and
  • c) A logical connection exists between the medical complaint, the medical history, and the physical examination and the drug prescribed.

This definition establishes the bare minimum standards, and all providers, doctors, nurses, and other such practitioners affiliated with MultiMedRx™ (MMRx). MultiMedRx™ (MMRx) follow all applicable federal, state, and local laws regarding the practice of telehealth as required.

5. Legal Compliance

All providers, doctors, nurses, and other such practitioners affiliated with MultiMedRx™ (MMRx). MultiMedRx™ (MMRx) comply fully with state laws and regulations; the Federal Food, Drug, and Cosmetic Act; and the Federal Controlled Substances Act. We do not facilitate the prescribing or dispensing of, or offer to facilitate the prescribing or dispensing of, any commercial medications that have not been approved by the US Food and Drug Administration (FDA). Compounded medications are exclusively compounded at licensed 503(a) compounding pharmacies pursuant to Section 503A of the Federal Food, Drug, and Cosmetic Act.

MultiMedRx home

MMRx Locations

  • Main Office
    1000 Quail St. #260, Newport Beach, CA 92660
  • Telehealth Location
    401 Ryland St. #200-A, Reno, NV 89502

Quick Links

  • MultiMedRx Home
  • SMS Opt-in
  • Contact

Licenses

NPI Number: 1538565072
Taxonomy: 174400000X
Provider Enumeration Date: 11/11/2014

Contact Us

  • 800.787.9659
  • [email protected]
  • Contact Page

© 2026 MultiMedRX LLC. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
  • Legal Compliance
  • Return & Refund Policy
  • Notice of Privacy Practices
  • SMS Terms

Disclosures

* Weight loss not guaranteed. Individual results vary and not all patients will qualify for treatment. Images, photos, and statements are for illustrative purposes only and do not guarantee outcomes.

** All medications are prescription-only and provided only after evaluation by a licensed healthcare provider. Telehealth services are subject to provider approval and clinical eligibility. Clinically appropriate treatment may include GLP-1 medications (e.g., semaglutide or tirzepatide). Weight-loss counseling and other services are offered as clinically appropriate.

§ Prices apply only to patients approved by a licensed provider. Prepaid plan prices require payment of the full plan total. Offers may vary by state and eligibility.

† Medications and services may vary by state.

‡ MultiMedRx is not affiliated with the manufacturers of Ozempic®, Wegovy®, Zepbound®, or any other referenced medications. See a licensed provider for complete safety information.

¶ Compounded medications are prepared by a licensed pharmacy for an individual patient. They are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality.

Important Safety Information

  1. Common side effects of GLP-1 medications include nausea, vomiting, diarrhea, constipation, and abdominal pain. Serious risks include pancreatitis, gallbladder disease, low blood sugar, kidney problems, and thyroid C-cell tumors.
  2. Tirzepatide has a Boxed Warning for thyroid C-cell tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. Serious risks include pancreatitis, gallbladder disease, low blood sugar, kidney problems, and GI complications.